Christina brings her passion for healthcare to Vaxxinity with 25 years of proven leadership in the production and delivery of transformative medicines. As Chief Operating Officer, she oversees all operations of the production and distribution of the company’s products, including supply chain, program management, human resources and information technology. Prior to joining Vaxxinity, Christina was the Chief Operations Officer at Dendreon Pharmaceuticals, LLC, with the responsibility of leading over 400 employees and managing all operational aspects for the production, disposition and delivery of the first FDA-approved immunotherapy treatment for advanced prostate cancer. Before Dendreon, Christina worked on commercializing multiple novel therapeutics in a Quality role with Amgen and drug development with Xenogen Corporation and Targeted Genetics Corporation. Christina earned a B.S. in Cell and Molecular Biology from the University of Washington, Seattle, WA.